CMS Belgium and CMS France advised Biogroup in connection with the acquisition of CMA-Medina

CMS Belgium and CMS France advised Biogroup in connection with the acquisition of the Belgian clinical lab Group CMA-Medina. With this acquisition, the largest private clinical blood analysis groups in France and Belgium are joining forces. 

CMS acted as legal and tax advisor, alongside investment bank Degroof Petercam and financial advisors EY and KPMG.

The CMS team advising Biogroup in Belgium was lead by Arnaud Van Oekel and comprised David Prync, Candice Kunkera and Lola Verelst for the Corporate/M&A aspects, Bruno Fonteyn (regulatory), Sophie Berg (HR) and Olivier Querinjean and his team for the tax aspects.

The CMS France team comprised Christophe Blondeau, Benoit Gomel, Célia Mayran, Noëlle Boualem and Marion Bladé for the Corporate/M&A aspects and Jean-Charles Benois, Alexia Cayrel, Vincent Forestier and Thomas Louvel for the tax aspects.